Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza Timing in Cataract Surgery (SITE Study)
NCT05143281Phase 4Completed
- Sponsor
- Grene Vision Group
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in post-operative ocular inflammation, post-operative ocular pain, sponsored by Grene Vision Group. Started Dec 2021; status: completed.
02
Drugs
ozurdex
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT05143281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05143281.